Private Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.65M | Buy |
|
|||||
|
2025
Q2 | $5.45M | Buy |
|
|||||
|
2025
Q1 | $3.69M | Buy |
|
|||||
|
2024
Q4 | $3.35M | Buy |
|
|||||
|
2024
Q3 | $3.37M | Sell |
|
|||||
|
2024
Q2 | $4.19M | Buy |
|
|||||
|
2024
Q1 | $923K | Buy |
|
|||||
|
2023
Q4 | $559K | Buy |
|
|||||
|
2023
Q3 | $254K | Buy |
|
|||||
|
2023
Q2 | $283K | Buy |
|
|||||
|
2023
Q1 | $225K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $407K | Buy |
|
|||||
|
2022
Q2 | $370K | Sell |
|
|||||
|
2022
Q1 | $404K | Sell |
|
|||||
|
2021
Q4 | $868K | Sell |
|
|||||
|
2021
Q3 | $1.45M | Buy |
|
|||||
|
2021
Q2 | $1.6M | Sell |
|
|||||
|
2021
Q1 | $1.27M | Buy |
|
|||||
|
2020
Q4 | $1.2M | Buy |
|
|||||
|
2020
Q3 | $375K | Sell |
|
|||||
|
2020
Q2 | $383K | Buy |
|
|||||
|
2020
Q1 | $206K | Sell |
|
|||||
|
2019
Q4 | $469K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $205K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $366K | Buy |
|
|||||
|
2018
Q2 | $227K | Buy |
|